SCIRP Mobile Website
Paper Submission

Why Us? >>

  • - Open Access
  • - Peer-reviewed
  • - Rapid publication
  • - Lifetime hosting
  • - Free indexing service
  • - Free promotion service
  • - More citations
  • - Search engine friendly

Free SCIRP Newsletters>>

Add your e-mail address to receive free newsletters from SCIRP.

 

Contact Us >>

Article citations

More>>

Hu-Lieskovan, S., Vallbohmer, D., Zhang, W., Yang, D., Pohl, A., Labonte, M.J., et al. (2011) EGF61 Polymorphism Predicts Complete Pathologic Response to Cetuximab-Based Chemotherapy Independent of KRAS Status in Locally Advanced Rectal Cancer Patients. Clinical Cancer Research, 17, 5161-5169. http://dx.doi.org/10.1158/1078-0432.CCR-10-2666

has been cited by the following article: